Clinical Takeaway Cannabinoid-based treatments, including CBD-rich preparations, have shown early promise for reducing certain behavioral symptoms in autism spectrum disorder, such as irritability, hyperactivity, and sleep disturbances. The evidence comes from a...
`Cannabinoid Clinical Trials: CBD and Cortical Excitability`
Clinical Takeaway In a controlled crossover trial of healthy adults, CBD at both low (30 mg) and high (700 mg) single doses showed no direct effect on cortical excitability compared to placebo....
Cannabinoid Clinical Trials: EEG Sleep Insomnia RCT
Clinical Takeaway In this small pilot trial of 20 adults with diagnosed insomnia disorder, a single oral dose of 10 mg THC combined with 200 mg CBD reduced total sleep time compared...
`Cannabinoid Clinical Trials: CBD vs Placebo in Fibromyalgia`
Clinical Takeaway In this randomized, double-blind, placebo-controlled trial, CBD did not demonstrate superiority over placebo in reducing pain among patients with fibromyalgia. The findings do not support the use of CBD as...
Endocannabinoid System Clinical Research: 2024 RCT Finds
Clinical Takeaway A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use concerns during a high-risk transition period. The study evaluated whether...
`Cannabinoid Clinical Trials: Cannabis for Chronic Back Pain`
Clinical Takeaway In this phase 3 trial of 820 adults, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks for chronic low back pain, with longer-term follow-up extending to...
Endocannabinoid System Research: Cannabis in Mental Health Care
Clinical Takeaway A randomized controlled trial tested the Minder mobile app, co-designed with university students, for addressing mental health and substance use challenges during the college transition period. Digital tools like this...
endocannabinoid system clinical research: Minder RCT
Clinical Takeaway A mobile app called Minder, co-developed with university students, was tested in a randomized controlled trial to evaluate its impact on mental health and substance use outcomes in a general...
`Cannabinoid Clinical Trials: Cannabis in Student Mental Health`
Clinical Takeaway A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use concerns during the high-risk college transition period. Digital tools like...
`Cannabinoid Clinical Trials: Full-Spectrum Cannabis for Back Pain`
Clinical Takeaway In this phase 3 trial of 820 adults with chronic low back pain, the full-spectrum cannabis extract VER-01 was evaluated against placebo over 12 weeks with up to 12 additional...